Literature DB >> 17327387

Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization.

Renato Fanchin1, Daniel H Mendez Lozano, Nelly Frydman, Alain Gougeon, Nathalie di Clemente, René Frydman, Joëlle Taieb.   

Abstract

CONTEXT: The strong relationship between serum anti-Müllerian hormone (AMH) levels and the number of antral follicles supports the use of AMH measurements as a quantitative marker of the ovarian follicular status. Yet, it still is unclear whether the aptitude of an individual follicle to produce AMH reflects its reproductive competence.
OBJECTIVE: This study examined the possible relationship between serum or follicular fluid (FF) AMH concentrations and the fate of the ensuing oocytes and embryos obtained by in vitro fertilization-embryo transfer conducted in monodominant follicle cycles. DESIGN AND
SETTING: We conducted a prospective study at the University of Paris XI, Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale U782. PATIENTS: Patients included 118 infertile in vitro fertilization-embryo transfer candidates.
INTERVENTIONS: Concentrations of AMH, progesterone, and estradiol were measured in the serum on cycle d 3 and on the day of oocyte pickup (dOPU), and in FF. Cycles were sorted into three sets of three distinct groups according to whether serum d 3, serum dOPU, and FF AMH concentrations were 30th centile or below (low AMH), between the 31st and the 70th centiles (average AMH), or above the 70th centile (high AMH) of measurements. MAIN OUTCOME MEASURE: Clinical pregnancy and embryo implantation rates were assessed.
RESULTS: Clinical pregnancy rates (5.7, 20.0, and 39.5%, respectively; P < 0.002) and embryo implantation rates (11.8, 30.8, and 65.4, respectively; P <0.001) were markedly different among the low, moderate, and high FF AMH groups but not among the serum (d 3 or dOPU) AMH groups. Fertilization rates and embryo morphology remained similar irrespective of AMH concentrations in the serum or in FF. Incidentally, FF AMH concentrations were negatively correlated with FF progesterone (r = -0.27; P <0.003) and FF estradiol (r = -0.21; P <0.02) concentrations.
CONCLUSIONS: Concentrations of AMH in the FF, but not in the serum, constitute a useful follicular marker of embryo implantation and are negatively related to FF progesterone and estradiol concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327387     DOI: 10.1210/jc.2006-1053

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis.

Authors:  Lingnv Yao; Wei Zhang; Hong Li; Wenqin Lin
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis.

Authors:  Gengxiang Wu; N A Bersinger; M D Mueller; M von Wolff
Journal:  J Assist Reprod Genet       Date:  2017-01-10       Impact factor: 3.412

3.  Why more is less and less is more when it comes to ovarian stimulation.

Authors:  Zeev Blumenfeld
Journal:  J Assist Reprod Genet       Date:  2015-10-19       Impact factor: 3.412

4.  Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes.

Authors:  Katherine L Palmerola; Briana J Rudick; Rogerio A Lobo
Journal:  J Assist Reprod Genet       Date:  2018-04-27       Impact factor: 3.412

Review 5.  Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Authors:  Akira Iwase; Tomoko Nakamura; Satoko Osuka; Sachiko Takikawa; Maki Goto; Fumitaka Kikkawa
Journal:  Reprod Med Biol       Date:  2015-11-23

6.  Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.

Authors:  Daniel A Dumesic; Timothy G Lesnick; Jacques P Stassart; G David Ball; Ashley Wong; David H Abbott
Journal:  Fertil Steril       Date:  2009-07       Impact factor: 7.329

7.  Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies.

Authors:  Hind A Beydoun; Laurel Stadtmauer; May A Beydoun; Helena Russell; Yueqin Zhao; Sergio Oehninger
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

8.  Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center.

Authors:  Caitlin R Sacha; Jorge E Chavarro; Paige L Williams; Jennifer Ford; LiHua Zhang; Patricia K Donahoe; Irene C Souter; Russ Hauser; David Pépin; Lidia Mínguez-Alarcón
Journal:  J Assist Reprod Genet       Date:  2020-10-06       Impact factor: 3.412

9.  The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).

Authors:  Wen-Qin Lin; Ling-Nv Yao; Dong-Xue Zhang; Wei Zhang; Xiao-Jing Yang; Rong Yu
Journal:  J Assist Reprod Genet       Date:  2013-03-17       Impact factor: 3.412

10.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.